Table 2.

Clinical outcomes of oral versus intravenous treatment for patients with CAP.

A	Oral (n = 71)	Intravenous (n = 102)	OR	95% CI	p value	aOR	95% CI	p value
Mortality, n (%)	4 (5.6)	8 (7.8)	1.2	0.4–5.0	0.76	1.1	0.3–4.7	0.84
ICU-admission, n (%)	1 (1.4)	6 (5.9)	3.0	0.6–80.1	0.23	2.8	0.6–73.2	0.23
Readmission within 7 days, n (%)	4 (4.6)	9 (8.8)	1.7	0.6–6.9	0.36	1.7	0.5–6.8	0.37

B	Oral (n = 71)	Intravenous (n = 102)	β	95% CI	p value	aβ	95% CI	p value
Length of stay (days), median [IQR]a	2 [0–4]	4 [2–6]	2.6	1.2–4.0	< 0.001	2.6	1.2–4.0	< 0.001
Length of stay (days), median [IQR]b	3 [2–6]	4 [2–6]	1.3	− 0.3 to 3.0	0.12	1.4	− 0.3 to 3.0	0.10
Length of antibiotic treatment (days), median [IQR]	7 [5–7.5]	6.5 [5.3–9]	2.1	− 0.2 to 4.4	0.08	2.2	− 0.1 to 4.6	0.06

(A) Logistic regression (B) Linear regression. CI confidence interval, ICU intensive care unit, OR odds ratio, β = effect size in days. aOR and Aβ odds ratio and effect size adjusted for the propensity score. aOR Adjusted odds ratio, CI confidence interval, ICU intensive care unit, OR odds ratio. ^aOutcomes for only non-deceased patients: 67 treated orally, 93 treated intravenously. ^bOutcomes for only hospitalised, non-deceased patients: 45 patients treated orally, 93 treated intravenously.